TCN-202

DB17777InvestigationalProtein Based Therapies

TCN-202: Overview.

Also known as
TCN-202 (human anti-cytomegalovirus monoclonal antibody)
Code names
TCN-202

Resolves to

Compound
UNIIY305H9E76N

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of TCN-202, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In